SEC Form 4 · accession 0001193125-26-380023
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willis C Lee
Officer — CEO · Director
Period of report
May 30, 2025
Accepted (ET)
Sep 2, 2026 · 3:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.001 par valueF1 | May 30, 2025 | P | 70,000 | $0.02 | A | 229,400 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par valueF2 | Aug 29, 2025 | P | 170,000 | $0.01 | A | 275,400 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par valueF3 | Aug 25, 2026 | P | 46,000 | $0.04 | A | 445,400 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par valueF4 | Aug 27, 2026 | P | 50,000 | $0.05 | A | 495,400 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par valueF5 | Aug 28, 2026 | P | 94,767 | $0.06 | A | 590,167 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par valueF6 | Aug 31, 2026 | P | 100,000 | $0.05 | A | 690,167 | I | Fidelity Roth IRA FBO Willis C. Lee |
| Common stock, $0.001 par value | holding | — | — | — | 395,124 | D | ||
| Common stock, $0.001 par value | holding | — | — | — | 241,194 | I | Fidelity Traditional IRA FBO Willis C. Leeee |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6).
- F2The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive.
- F3The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive.
- F4The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive.
- F5The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive.
- F6The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive.